BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 30194818)

  • 1. Refining the phenotype associated with GNB1 mutations: Clinical data on 18 newly identified patients and review of the literature.
    Hemati P; Revah-Politi A; Bassan H; Petrovski S; Bilancia CG; Ramsey K; Griffin NG; Bier L; Cho MT; Rosello M; Lynch SA; Colombo S; Weber A; Haug M; Heinzen EL; Sands TT; Narayanan V; Primiano M; Aggarwal VS; Millan F; Sattler-Holtrop SG; Caro-Llopis A; Pillar N; Baker J; Freedman R; Kroes HY; Sacharow S; Stong N; Lapunzina P; Schneider MC; Mendelsohn NJ; Singleton A; Loik Ramey V; Wou K; Kuzminsky A; Monfort S; Weiss M; Doyle S; Iglesias A; Martinez F; Mckenzie F; Orellana C; van Gassen KLI; Palomares M; Bazak L; Lee A; Bircher A; Basel-Vanagaite L; Hafström M; Houge G; ; ; Goldstein DB; Anyane-Yeboa K
    Am J Med Genet A; 2018 Nov; 176(11):2259-2275. PubMed ID: 30194818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Germline De Novo Mutations in GNB1 Cause Severe Neurodevelopmental Disability, Hypotonia, and Seizures.
    Petrovski S; Küry S; Myers CT; Anyane-Yeboa K; Cogné B; Bialer M; Xia F; Hemati P; Riviello J; Mehaffey M; Besnard T; Becraft E; Wadley A; Politi AR; Colombo S; Zhu X; Ren Z; Andrews I; Dudding-Byth T; Schneider AL; Wallace G; ; Rosen ABI; Schelley S; Enns GM; Corre P; Dalton J; Mercier S; Latypova X; Schmitt S; Guzman E; Moore C; Bier L; Heinzen EL; Karachunski P; Shur N; Grebe T; Basinger A; Nguyen JM; Bézieau S; Wierenga K; Bernstein JA; Scheffer IE; Rosenfeld JA; Mefford HC; Isidor B; Goldstein DB
    Am J Hum Genet; 2016 May; 98(5):1001-1010. PubMed ID: 27108799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel GNB1 de novo mutation in a patient with neurodevelopmental disorder and cutaneous mastocytosis: Clinical report and literature review.
    Szczałuba K; Biernacka A; Szymańska K; Gasperowicz P; Kosińska J; Rydzanicz M; Płoski R
    Eur J Med Genet; 2018 Mar; 61(3):157-160. PubMed ID: 29174093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous mastocytosis in a child with a de novo GNB1 mutation.
    Lattanzio K; Larijani M; Treat JR
    Pediatr Dermatol; 2022 Mar; 39(2):328-329. PubMed ID: 35119134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotype-genotype correlations in patients with GNB1 gene variants, including the first three reported Japanese patients to exhibit spastic diplegia, dyskinetic quadriplegia, and infantile spasms.
    Endo W; Ikemoto S; Togashi N; Miyabayashi T; Nakajima E; Hamano SI; Shibuya M; Sato R; Takezawa Y; Okubo Y; Inui T; Kato M; Sengoku T; Ogata K; Hamanaka K; Mizuguchi T; Miyatake S; Nakashima M; Matsumoto N; Haginoya K
    Brain Dev; 2020 Feb; 42(2):199-204. PubMed ID: 31735425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel GNB1 mutations disrupt assembly and function of G protein heterotrimers and cause global developmental delay in humans.
    Lohmann K; Masuho I; Patil DN; Baumann H; Hebert E; Steinrücke S; Trujillano D; Skamangas NK; Dobricic V; Hüning I; Gillessen-Kaesbach G; Westenberger A; Savic-Pavicevic D; Münchau A; Oprea G; Klein C; Rolfs A; Martemyanov KA
    Hum Mol Genet; 2017 Mar; 26(6):1078-1086. PubMed ID: 28087732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GNB1 Encephalopathy: Clinical Case Report and Literature Review.
    Nasvytis M; Čiauškaitė J; Jurkevičienė G
    Medicina (Kaunas); 2024 Apr; 60(4):. PubMed ID: 38674235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dystonia with myoclonus and vertical supranuclear gaze palsy associated with a rare GNB1 variant.
    Reyes NGD; Di Luca DG; McNiven V; Lang AE
    Parkinsonism Relat Disord; 2023 Jan; 106():105239. PubMed ID: 36521323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haploinsufficiency as a disease mechanism in GNB1-associated neurodevelopmental disorder.
    Schultz-Rogers L; Masuho I; Pinto E Vairo F; Schmitz CT; Schwab TL; Clark KJ; Gunderson L; Pichurin PN; Wierenga K; Martemyanov KA; Klee EW
    Mol Genet Genomic Med; 2020 Nov; 8(11):e1477. PubMed ID: 32918542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent gene mutations detected in canine mast cell tumours by next generation sequencing.
    Vozdova M; Kubickova S; Pal K; Fröhlich J; Fictum P; Rubes J
    Vet Comp Oncol; 2020 Dec; 18(4):509-518. PubMed ID: 31999054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comment on "Cutaneous mastocytosis in a child with a de novo GNB1 mutation".
    Ramírez CG; Azaña Defez JM; Clemente SP; Sanz PL; Córdoba SM
    Pediatr Dermatol; 2023; 40(6):1164-1165. PubMed ID: 37970691
    [No Abstract]   [Full Text] [Related]  

  • 12. Acute lymphoblastic leukemia in a child with a de novo germline gnb1 mutation.
    Brett M; Lai AH; Ting TW; Tan AM; Foo R; Jamuar S; Tan EC
    Am J Med Genet A; 2017 Feb; 173(2):550-552. PubMed ID: 27759915
    [No Abstract]   [Full Text] [Related]  

  • 13. Atypical clinical course in two patients with GNB1 variants who developed acute encephalopathy.
    Tsuji M; Ikeda A; Tsuyusaki Y; Iai M; Kurosawa K; Kosaki K; Goto T
    Brain Dev; 2023 Sep; 45(8):462-466. PubMed ID: 37453880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Second patient with GNB2-related neurodevelopmental disease: Further evidence for a gene-disease association.
    Lansdon LA; Fleming EA; Viso FD; Sullivan BR; Saunders CJ
    Eur J Med Genet; 2021 Jul; 64(7):104243. PubMed ID: 33971351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in G protein β subunits promote transformation and kinase inhibitor resistance.
    Yoda A; Adelmant G; Tamburini J; Chapuy B; Shindoh N; Yoda Y; Weigert O; Kopp N; Wu SC; Kim SS; Liu H; Tivey T; Christie AL; Elpek KG; Card J; Gritsman K; Gotlib J; Deininger MW; Makishima H; Turley SJ; Javidi-Sharifi N; Maciejewski JP; Jaiswal S; Ebert BL; Rodig SJ; Tyner JW; Marto JA; Weinstock DM; Lane AA
    Nat Med; 2015 Jan; 21(1):71-5. PubMed ID: 25485910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel GNB1 missense mutation in a patient with generalized dystonia, hypotonia, and intellectual disability.
    Steinrücke S; Lohmann K; Domingo A; Rolfs A; Bäumer T; Spiegler J; Hartmann C; Münchau A
    Neurol Genet; 2016 Oct; 2(5):e106. PubMed ID: 27668284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic analysis of IRF2BPL in a Taiwanese dystonia cohort: The genotype and phenotype correlation.
    Chen PS; Chen YF; Chiu JY; Wu MC; Tai CH; Chang YY; Lan MY; Lee NC; Lin CH
    Ann Clin Transl Neurol; 2024 Jun; 11(6):1557-1566. PubMed ID: 38650104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of the Asn306Ser variant of the SP4 transcription factor and an intronic variant in the beta-subunit of transducin with digenic disease.
    Gao YQ; Danciger M; Ozgul RK; Gribanova Y; Jacobson S; Farber DB
    Mol Vis; 2007 Feb; 13():287-92. PubMed ID: 17356515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mosaicism of de novo pathogenic SCN1A variants in epilepsy is a frequent phenomenon that correlates with variable phenotypes.
    de Lange IM; Koudijs MJ; van 't Slot R; Gunning B; Sonsma ACM; van Gemert LJJM; Mulder F; Carbo EC; van Kempen MJA; Verbeek NE; Nijman IJ; Ernst RF; Savelberg SMC; Knoers NVAM; Brilstra EH; Koeleman BPC
    Epilepsia; 2018 Mar; 59(3):690-703. PubMed ID: 29460957
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.